OVERVIEW

A 3D View Targeting Inflammatory Cytokines: Addressing Articular and Systemic Pathology in Patients with Moderate-to-Severe Rheumatoid Arthritis is organized by Med Learning Group and will be held from Nov 13, 2018 - Nov 13, 2019.

Target Audience:
This enduring activity is designed to meet the educational needs of primarily rheumatologists with a secondary audience of internists and allied healthcare professionals involved in the care of patients with rheumatoid arthritis.

Accreditation:
Credit Designation Statement:
Med Learning Group designates this online activity for a maximum of 1.5 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the online activity.
Nursing Credit Information:
Purpose: This program would be beneficial for nurses involved in the long-term treatment and management of patients with rheumatoid arthritis. CNE Credits: 1.5 ANCC Contact Hours.

Program Overview:
This case-based online activity will cover the treatment and management of patients with moderate-to-severe rheumatoid arthritis.

Learning Objectives:
Upon the completion of this program, attendees should be able to:
• Describe the role of inflammatory cytokines, both articulately and systemically, in the pathogenesis of rheumatoid arthritis
• Review the clinical trials data supporting the medical society pharmacologic recommendations for patients with moderate-to-severe rheumatoid arthritis
• Discuss the use of interleukin-6 inhibition as a treat-to-target strategy in patients with moderate-to-severe rheumatoid arthritis.

Additioanl details will be posted as soon as they are available.